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Abstract
Negative autopsy is a post-mortem examination in which a comprehensive analysis does 
not provide a cause of death. These include situation of death, anatomical and histologi-
cal analysis, toxicology and microbiological study. A low part of autopsies remain with-
out a conclusive cause of death, but all these cases are usually seen in young population, 
apparently healthy who died suddenly and unexpectedly. In these situations a cardiac 
arrhythmia is suspected as cause of death and genetic testing is recommended despite 
not regularly performed. Sudden death is a natural and unexpected decease that occurs 
in apparently healthy people, or whose disease was not severe enough to expect a fatal 
outcome. It can be due to several pathologies, usually of cardiac cause and called sudden 
cardiac death. In infants and young people, both long QT syndrome and catecholamin-
ergic polymorphic ventricular tachycardia are main causes in negative autopsies. These 
genetic diseases lead to ventricular fibrillation, syncope and sudden cardiac death in a 
normal heart. Unfortunately, sudden cardiac death could be the first manifestation of 
the diseases, being early identification and prevention a crucial point in current medical 
practice. This chapter focuses on sudden death and negative autopsy in young popula-
tion, mainly due to cardiac arrhythmias.
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1. Introduction
An autopsy is a post-mortem examination of a deceased person in order to unravel the cause 
and time of death. In 5% of all cases, the autopsy may be classified as negative, concerning 
that no conclusive cause of death is identified after comprehensive analysis of all data recom-
piled. These data included gross and microscopically examination, and laboratory investiga-
tions [1]. Hence, unexplained death or “mors sine materia” is defined as “the death that remains 
unsolved after a thorough autopsy, of an individual without previous cardiac history and who has been 
seen alive within the previous 12 hours of the death” [2]. In these situations, cardiac death due to 
electric disorders without heart structural alterations could be considered the most common 
origin of the death [3]. Most part of these SD occurs in infants -sudden infant death syndrome 
(SIDS)-, and young population [4]. The two main disease associated with cardiac arrhythmias 
are long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia 
(CPVT). Both arrhythmias are of genetic origin and characterized with typical parameters in 
the electrocardiogram (ECG). For this reason, preventive medicine recommends to perform 
an ECG in all infants and young population (at least one ECG before 14 years old) in order 
to identify ECG alterations and, if positive, adopt preventive therapeutic measures to avoid a 
malignant arrhythmia. Unfortunately, the first manifestation of one cardiac arrhythmia may 
be the SCD, without previous symptoms.
Genetic analysis in post-mortem patients (also called molecular autopsy) may identify the 
genetic alteration responsible for an arrhythmogenic cardiac disease [5]. Current guidelines 
recommend performing the molecular autopsy in all these cases as a part of the comprehen-
sive medico-legal investigation in SCD cases [6] but post-mortem genetic testing of the pro-
band was reported in a low percentage of SCD cases with no structural alterations patients 
[7–9], mainly because forensic centers do not have the economic resources to perform genetic 
testing or do not collect samples due to currently legal restrictions involved with the sam-
pling and storage of DNA [10]. Use of next generation sequencing technology (NGS) allows a 
comprehensive genetic analysis of all genes associated with SCD and cardiac arrhythmias, in 
a reduced time and in a cost-effective way, solving the economic problem. Due to genetic ori-
gin, family members could be also affected by the disease and at risk of SCD, despite asymp-
tomatic. Therefore, both clinical and genetic analysis should be performed in all relatives, 
and interviewing family members may reveal helpful information not discovered in the ini-
tial research. It has been recommended that all relatives of unexplained SD victims undergo 
evaluation by a multidisciplinary team of cardiologists, forensic pathologists and geneticists 
[7] because of the investigation of an unexplained SD is extremely complicated in the families 
of the victims, mainly when the victim is a child (SIDS) [11, 12].
2. Inherited arrhythmias
Nowadays, nearly 85% of all SD are of cardiac origin (SCD) being responsible for around 
30–200/100.000 yearly [13]. In population major 50 years old, around 80% of SCD cases are 
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consequence of coronary disease [14], but in the younger population (less than 35 years) the 
cause is mainly due to inherited arrhythmias of genetic origin [15]. This last collection of dis-
eases can be classified into two main groups [16]:
2.1. Cardiomyopathies
Arrhythmia is induced by structural abnormalities. These anatomical modifications are 
caused by alterations in genes encoding three types of proteins: sarcomeric which mainly 
cause hypertrophic cardiomyopathy (HCM); cytoskeletal, which mainly cause dilated car-
diomyopathy (DCM), and desmosomal alterations, which mainly cause arrhythmogenic car-
diomyopathy (ACM) [17]. These diseases imply a structural alteration of the heart, usually 
identified during an autopsy examination. In early stages of the disease, the alteration may 
be only identified using microscopic analysis but not at gross level. Curiously, both in SIDS 
and young people died suddenly, recent studies identified genetic alteration associated with 
any of these diseases but without any cardiac alteration, neither macroscopic nor microscopic. 
It could be explained because of the first structural alterations induced by the disease occurs 
at ultramicroscopic level (identified using only electronic microscopic). The electrical distur-
bance prior to malignant arrhythmia could be induced by these ultra-structural alterations. 
Hence, negative autopsy of infant and young population carrying alterations in genes encod-
ing cardiomyopathies should not be discarding without a comprehensive analysis [18].
2.2. Channelopathies
Arrhythmogenic substrate is found in the electrical properties of the heart because genetic 
alterations occur in genes encoding for ion channels, their subunits or associated proteins 
playing a key role in the function of the channel. Ion channel diseases are not accompanied 
by structural cardiac defects and their first manifestation is a malignant arrhythmia or even 
SCD [19]. Cardiac channelopathies may be clinically identified only by the presence of some 
characteristic ECG abnormalities [20]. However, incomplete penetrance and variable expres-
sivity in inherited arrhythmogenic disorders imply that the distinctive ECG patterns that 
characterize these disorders may be masked. When a SD occurs in a healthy young indi-
vidual with no previous symptoms of any disease, arrhythmia is suspected as explanation 
of the disease but only identification of a genetic alteration may help us to identify the cause 
of the arrhythmia, and therefore, the cause of the death. Nowadays, hundreds of pathogenic 
variants have been identified in more than 40 genes, affecting sodium, potassium or calcium 
ion currents and depending on which ion channel is affected, different syndromes will be 
present [21]. Nevertheless, the same syndrome may show a certain degree of overlap if dif-
ferent types of channel can be affected. However, knowledge is not limited to the familial 
form, as it opens up new hypotheses as to how the gene interacts with the environment, 
drugs, and damaged muscle, and how arrhythmias arise in acquired or non-inherited forms 
[22]. This group includes LQTS, CPVT but also Brugada syndrome (BrS), and short QT syn-
drome (SQTS), among others [23]. In this chapter we will focus mainly in these diseases 
because of negative autopsy implies no cardiac abnormalities identified during post-mortem 
examination.
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3. Long QT syndrome
This lethal entity is characterized for a prolongation of the QT interval (QTc>460 ms women and 
>450 ms men). The clinical presentation can be variable, ranging from asymptomatic patients 
to syncope and even SCD, mainly due to ventricular tachyarrhythmias (torsade de pointes) in the 
setting of a structurally normal heart. The spectrum of ECG abnormalities inducing electrical 
instability includes notched or biphasic T waves and T wave alternant. The prevalence is esti-
mated in 1 of 2500 individuals [24, 25] being one of the leading causes of SCD among infants 
and young population. In recent years, massive ECG screening in young population has been 
performed with success of lowering rates of SD among infants and athletes [26]. In all patients, 
beta-blocker administration at high doses is highly recommended because it decreases the risk 
of SCD although do not provide full protection. The dose is adjusted according to the medi-
cal tolerance to these drugs (www.torsades.org). Implantable cardioverter-defibrillator (ICD) 
implantation is mandatory for those patients having had an aborted SCD and for those at risk of 
fatal arrhythmias [27]. LQTS can be acquired (associated with drugs and electrolyte imbalance 
such as hypokalemia, hypocalcaemia and hypomagnesaemia) or congenital (associated with 
pathogenic alterations in ion channels and/or associated proteins). Currently, more than 1000 
genetic alterations have been identified in 20 genes (AKAP9, ANK2, CACNA1C, CALM1, CALM2, 
CALM3, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, RYR2, SCN1B, SCN4B, SCN5A, 
SNTA1, TRDN and TRPM4). All these genes together are responsible for 80–85% of all LQT cases 
[28] (Figure 1). Major genes associated with LQTS are KCNQ1 –type 1- (30–35%), KCNH2 –type 
2- (25–30%) and SCN5A type 3- (5–10%) which are responsible for 65–75% of all LQTS cases 
[29]. A negative autopsy of a young case died suddenly (usually during exercise but also at rest) 
(Figure 2) could be caused by this arrhythmogenic entity.
Figure 1. All genes associated with cardiac channelopathies. LQTS, long QT syndrome. BrS, Brugada syndrome. SQTS, 
short QT syndrome. CPVT, catecholaminergic polymorphic ventricular tachycardia.
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4. Catecholaminergic polymorphic ventricular tachycardia
This entity is an inherited disorder with a normal ECG at rest (occasionally with bradycardia, 
and U waves), and triggered exclusively by adrenergic stimulus (mainly exertion, extreme 
stress or emotion). It is characterized in the ECG by a 2-way polymorphic ventricular tachy-
cardia in structural normal hearts [30]. It occurs mainly in children and adolescents and is 
increasingly recognized as a cause of unexplained SCD in young individuals, predominately 
in young males (30% by the age of 40 years) [31]. It was thought that the event happened 
in childhood (before age 10) with a high mortality rate [32]. Diagnosing CPVT can be dif-
ficult especially in young children. The first line of therapy is beta-blockers but ICDs are 
indicated for patients with aborted SCD or CPVT during exercise and in adolescents with 
incompletely controlled CPVT despite a high dose of medications [33]. Nowadays, more than 
200 pathogenic alterations have been reported in 8 genes (ANK2, CALM1, CALM2, CALM3, 
CASQ2, KCNJ2, RyR2 and TRDN) (Figure 1) and a comprehensive genetic analysis explains 
around 60% of CPVT cases. The main gene associated with CPVT is RyR2, being responsible 
of nearly 50% of all cases [34]. The ryanodine receptor is an intracellular calcium channel 
that is located in the sarcoplasmatic reticulum and activated by the influx of small amounts 
Figure 2. Distribution of arrhythmogenic diseases in negative autopsies. Most of deaths in young population before 
16 years old occur during day. Adrenergic situations are the triggers of the arrhythmia during daily activities (exercise, 
emotion). The main diseases responsible for these sudden deaths are long QT syndrome (LQTS) and catecholaminergic 
polymorphic ventricular tachycardia (CPVT). A less proportion of deaths occur during night, meanly in infants before 
2–3 years old. At rest, the main diseases associated with sudden death are LQTS and Brugada syndrome (BrS).
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of calcium, thereby allowing the outflow of stored calcium, being crucial in triggering heart 
muscle contraction. A negative autopsy of a young case died suddenly during exercise could 
be caused by this arrhythmogenic entity (Figure 2).
5. Brugada syndrome
This inherited disease was identified in 1992 by Pedro and Josep Brugada [35]. It is charac-
terized by an ECG pattern consisting of coved-type ST-segment elevation in atypical right-
bundle branch block in leads V1 to V3 (often referred to as type-1 Brugada ECG pattern), 
and an increased risk for SCD resulting from episodes of polymorphic ventricular tachyar-
rhythmias. The ECG pattern can be baseline or intermittent, and it can be unmasked during 
a drug test (class IC sodium channel-blockers). The prevalence of the disease is 4–12% of all 
SCD causes. The penetrance and expressivity of the disorder are highly variable, although 
it is considered a disorder involving mainly young male adults (about 40 years old), and 
SCD typically occurring during sleep. Patients with BrS usually remain asymptomatic and 
modulating factors such as fever, exercise or drugs (www.brugadadrugs.org), may play a 
major role in the dynamic nature of the ECG. After surviving a cardiac arrest or the occur-
rence of syncope, the only treatment having any proven effect on the prevention of sudden 
death is the implantable cardioverter-defibrillator (ICD) [36]. However, ICD implantation 
in symptomatic is not free from controversy, especially in children [37]. The first genetic 
alteration was identified in 1998 [38]. Nowadays, 24 genes have been associated to the dis-
ease (ABCC9, CACNA1C, CACNA2D1, CACNB2b, GPD1-L, HCN4, HEY2, KCND2, KCND3, 
KCNE3, KCNE5, KCNH2, KCNJ8, LRRC10, PKP2, RANGRF, SCN10A, SCN1B, SCN2B, 
SCN3B, SCN5A, SEMA3A, SLMAP and TRPM4) (Figure 1) but a comprehensive genetic 
analysis only identify the genetic alteration in a 35% of cases. Approximately 30% of patients 
with BrS carry a loss of function genetic alteration in SCN5A (BrS type 1) [37]. This gene is 
responsible for the phase 0 of the cardiac action potential, a key player in the cardiac electri-
cal activity. Hence, current guidelines only recommend genetic analysis of this gene [29]. A 
negative autopsy of a young case died during night could be caused by this arrhythmogenic 
entity (Figure 2).
6. Short QT syndrome
This arrhythmogenic disease was reported in 2000 [39]. It is a rare and highly lethal arrhyth-
mic disease entity characterized by a short QT interval in ECG (<330 ms), with a high sharp T 
wave and a short interval between the peak and the end of the T wave, leading some clinical 
manifestations from lack of symptoms to syncope, and even SCD. Clinical manifestations 
may appear in infants and young population, being considered one of the main causes SIDS 
[40]. Nowadays there is no pharmacological therapy of proven efficacy to prevent arrhyth-
mias and the implant of an ICD is the only alternative for high-risk cases. Nowadays, few 
pathogenic alterations have been identified in 6 different genes encoding potassium and 
calcium ion channels (KCNQ1, KCNJ2, KCNH2, CACNA1C, CACNB2 and CACNA2D1) 
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(Figure 1), following an autosomal dominant pattern of inheritance [41]. It should be a high 
penetrance and a comprehensive genetic analysis identifies the genetic alteration in nearly 
60% of clinically diagnosed cases. A negative autopsy of an infant case (less than 2 years) 
died suddenly could be caused by this arrhythmogenic entity (Figure 2).
7. Next generation sequencing
The genetic revolution was initiated 20 years ago, firstly with the knowledge of the human 
genome and in last 10 years with the advances in genetic technology that have permitted 
the development of massively parallel sequencing (also called next generation sequencing). 
Hence, current NGS technologies allow a massive sequencing of genes, even whole exome 
and genomes. The advance is the reduced time and the cost-effective way in comparison to 
traditional Sanger sequencing. Traditional Sanger sequencing has high fidelity but is slow 
and quite expensive compared with next generation methods. However, Sanger remains as a 
gold standard in validation of alterations as well as family segregation. In recent 5 years, NGS 
technology has been implemented in forensic area, allowing a comprehensive post-mortem 
genetic analysis. Hence, molecular autopsy using NGS has identified the cause of the death in 
a large part of cases with a no conclusive cause of death after comprehensive autopsy proto-
col without genetic analysis [42]. Current guidelines recommend use of molecular autopsy in 
young cases classified as negative after an autopsy [29]. The NGS analysis requires a certain 
DNA quality and quantity; the best approach is obtaining DNA from post-mortem blood, 
conserved at 4°C. DNA from tissue can be also an option but the conservation should be at 
−20°C. Currently, DNA from formalin-fixed, paraffin-embedded (FFPE) is not an option due 
to formalin destroy DNA and no proper amplification is possible for NGS technology. After 
NGS analysis, the next challenge is the interpretation of data identified. Most part of altera-
tions remains as ambiguous significance and an exhaustive analysis of each variant should 
be performed before translation into clinical practice [43–45]. This will require sustained col-
laboration between geneticist, cardiologist and forensics for genetic data interpretation, to 
optimize cause of death in a negative autopsy but also in family members in order to adopt 
personalized therapies.
8. Conclusions
In infant and young population, unexpected SD remains as a main problem because usually 
the first manifestation of the disease is the death. In last 10 years, negative autopsy cases are 
being progressively more studied in order to identify the cause of death, especially in young 
population. Cases usually classified without conclusive cause of death have been comprehen-
sively analyzed and resolved. However, molecular autopsy is not performed in all forensic 
centers and large percentage of cases remains without a cause of death. Use of genetics in 
forensic area has improved diagnosis of negative autopsies, but also identification of relatives 
at risk of SCD. Early identification of individuals at risk allows adoption of therapeutic mea-
sures in prevention of new lethal episodes in infant and young population.
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